Official Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19
Brief Summary

This clinical trial will examine if a new treatment of Mesenchymal-like Adherent stromal Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

Active, not recruiting
COVID
ARDS

Biological: PLX-PAD

PLX-PAD, allogeneic ex vivo expanded placental mesenchymal-like adherent stromal cells

Biological: Placebo

Placebo solution for injection

Eligibility Criteria

Key Inclusion Criteria:

- Willing and able to provide written informed consent, or with a legal representative
who can provide informed consent.

- Male or non-pregnant female adult 40-80 years of age at time of enrollment.

- Laboratory-confirmed SARS-CoV-2 infection as determined by PCR, in any specimen up to
21 days prior to randomization.

- Meets definition of ARDS according to Berlin criteria.

Key Exclusion Criteria:

- Body weight under 55 kg (121 lbs)

- Serum creatinine level of over 1.5 mg/dL at time of randomization.

- Total Bilirubin ≥2 mg/dL at time of randomization.

- Known allergy to any of the following: dimethyl sulfoxide (DMSO), human serum albumin,
bovine serum albumin.

- Stroke or acute myocardial infarction/unstable angina within 3 months prior to
randomization.

- Chronic Obstructive Pulmonary disease GOLD stage above II.

Eligibility Gender
All
Eligibility Age
Minimum: 40 Years ~ Maximum: 80 Years
Countries
United States
Locations

University of California Irvine
Irvine, California, United States

University of Southern California (USC) - Keck School of Medicine (KSOM)
Los Angeles, California, United States

University Of California Davis,4860 Y Street
Sacramento, California, United States

Baptist Health Medical Center
Jacksonville, Florida, United States

Medical College of Georgia at Augusta University
Augusta, Georgia, United States

Sarah Cannon Research Institute, LLC (Mercer University School of Medicine)
Macon, Georgia, United States

University of Mississippi Medical Center
Jackson, Mississippi, United States

Cooper Research Institute
Camden, New Jersey, United States

Holy Medical Center
Teaneck, New Jersey, United States

Montefiore Medical Center
New York, New York, United States

Maimonides Medical Center
New York, New York, United States

Mercy Medical Center
New York, New York, United States

Thomas Jefferson University
Philadelphia, Pennsylvania, United States

Pluristem Ltd.
NCT Number